Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Family Practice · SUFFOLK, VA · NPI 1649271024
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 961 | 286 |
| Amlodipine Besylate | Amlodipine Besylate | 677 | 199 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 377 | 115 |
| Losartan Potassium | Losartan Potassium | 373 | 109 |
| Levothyroxine Sodium | Levothyroxine Sodium | 355 | 105 |
| Omeprazole | Omeprazole | 336 | 105 |
| Lisinopril | Lisinopril | 303 | 92 |
| Metformin Hcl | Metformin Hcl | 270 | 84 |
| Hydrochlorothiazide | Hydrochlorothiazide | 234 | 76 |
| Metformin Hcl Er | Metformin Hcl | 233 | 67 |
| Metoprolol Succinate | Metoprolol Succinate | 225 | 70 |
| Gabapentin | Gabapentin | 212 | 63 |
| Simvastatin | Simvastatin | 208 | 68 |
| Jardiance | Empagliflozin | 207 | 46 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 181 | 55 |
| Carvedilol | Carvedilol | 179 | 54 |
| Fluticasone Propionate | Fluticasone Propionate | 158 | 59 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 140 | 52 |
| Eliquis | Apixaban | 140 | 29 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 138 | 43 |
| Tamsulosin Hcl | Tamsulosin Hcl | 136 | 47 |
| Glimepiride | Glimepiride | 134 | 37 |
| Furosemide | Furosemide | 128 | 49 |
| Sertraline Hcl | Sertraline Hcl | 123 | 39 |
| Pravastatin Sodium | Pravastatin Sodium | 118 | 35 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 112 | 25 |
| Spironolactone | Spironolactone | 110 | 35 |
| Escitalopram Oxalate | Escitalopram Oxalate | 106 | 29 |
| Montelukast Sodium | Montelukast Sodium | 105 | 36 |
| Pantoprazole Sodium | Pantoprazole Sodium | 101 | 32 |
| Allopurinol | Allopurinol | 100 | 29 |
| Trazodone Hcl | Trazodone Hcl | 99 | 29 |
| Metoprolol Tartrate | Metoprolol Tartrate | 94 | 27 |
| Tramadol Hcl | Tramadol Hcl | 90 | 24 |
| Alendronate Sodium | Alendronate Sodium | 86 | 20 |
| Meloxicam | Meloxicam | 85 | 30 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 83 | 19 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 82 | 17 |
| Valsartan | Valsartan | 79 | 23 |
| Bupropion Xl | Bupropion Hcl | 78 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 73 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 73 | 25 |
| Ozempic | Semaglutide | 67 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 65 | 20 |
| Synthroid | Levothyroxine Sodium | 65 | 19 |
| Finasteride | Finasteride | 64 | 19 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 63 | 17 |
| Warfarin Sodium | Warfarin Sodium | 63 | 14 |
| Clonazepam | Clonazepam | 59 | suppressed |
| Memantine Hcl | Memantine Hcl | 59 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 57 | 19 |
| Potassium Chloride | Potassium Chloride | 56 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 55 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 51 | 23 |
| Lorazepam | Lorazepam | 48 | 17 |
| Pioglitazone Hcl | Pioglitazone Hcl | 48 | 16 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 47 | 22 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 44 | 25 |
| Fluoxetine Hcl | Fluoxetine Hcl | 43 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 42 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 41 | 21 |
| Ropinirole Hcl | Ropinirole Hcl | 41 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 38 | 11 |
| Ezetimibe | Ezetimibe | 36 | 11 |
| Farxiga | Dapagliflozin Propanediol | 36 | suppressed |
| Xarelto | Rivaroxaban | 36 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 35 | suppressed |
| Atenolol | Atenolol | 34 | 11 |
| Baclofen | Baclofen | 34 | suppressed |
| Ramipril | Ramipril | 34 | 11 |
| Alprazolam | Alprazolam | 33 | suppressed |
| Prednisone | Prednisone | 33 | 21 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 32 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 31 | suppressed |
| Famotidine | Famotidine | 30 | 11 |
| Mirtazapine | Mirtazapine | 30 | 11 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 28 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 28 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 26 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 26 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Naproxen | Naproxen | 25 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 24 |
| Oxycodone Hcl | Oxycodone Hcl | 25 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 25 | suppressed |
| Colchicine | Colchicine | 24 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 24 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 24 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 24 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 23 | suppressed |
| Ibuprofen | Ibuprofen | 23 | suppressed |
| Trulicity | Dulaglutide | 23 | suppressed |
| Ondansetron Odt | Ondansetron | 22 | suppressed |
| Estradiol | Estradiol | 21 | suppressed |
| Glipizide Er | Glipizide | 21 | suppressed |
| Mounjaro | Tirzepatide | 21 | suppressed |
| Nystatin | Nystatin | 21 | 12 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 21 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 20 | suppressed |
| Pregabalin | Pregabalin | 20 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 19 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 19 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 18 | suppressed |
| Diazepam | Diazepam | 17 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 17 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 17 | suppressed |
| Celecoxib | Celecoxib | 16 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 16 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 14 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 13 | suppressed |
| Lacosamide | Lacosamide | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Levetiracetam | Levetiracetam | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Tradjenta | Linagliptin | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Forteo | Teriparatide | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Dantrolene Sodium | Dantrolene Sodium | 11 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
| Rivastigmine | Rivastigmine | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error